✨ Health and Education Notices




1684

NEW ZEALAND GAZETTE

No. 71

for such capital works associated with, the buildings and
associated facilities of the above-mentioned integrated
schools as may be required or approved by the Minister of
Education, pursuant to section 40 (2) of the Private
Schools Conditional Integration Act 1975, or for meeting
debts, mortgages, liens, or other charges associated with

any of the land and buildings that constitute the integrated
schools.

Dated at Wellington this 5th day of July 2001.

KATHY PHILLIPS, Senior Manager, National Operations.

go4737

Health

Medical Practitioners Act 1995

Appointment to the Medical Council of New Zealand

Pursuant to 124 (b) of the Medical Practitioners Act 1995,
I appoint

Professor A. John Campbell

as a member of the Medical Council of New Zealand for a
term of office commencing on the date of notification in the
New Zealand Gazette and expiring on 30 June 2002.

Dated at Wellington this 3rd day of July 2001.

ANNETTE KING, Minister of Health.

go4788

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicine set out in the Schedule hereto:

Schedule

Product: Angiomax
Active Ingredient(s): Bivalirudin 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: The Medicines Company
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America

Product: Angiomax
Active Ingredient(s): Bivalirudin 250mg
Dosage Form: Powder for injection
New Zealand Sponsor: The Medicines Company
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America

Product: Zyprexa Zydis
Active Ingredient(s): Olanzapine 10mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer(s): Scherer DDS Ltd, Blagrove, Swindon, Wiltshire, England

Product: Zyprexa Zydis
Active Ingredient(s): Olanzapine 15mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer(s): Scherer DDS Ltd, Blagrove, Swindon, Wiltshire, England

Product: Zyprexa Zydis
Active Ingredient(s): Olanzapine 20mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer(s): Scherer DDS Ltd, Blagrove, Swindon, Wiltshire, England

Product: Zyprexa Zydis
Active Ingredient(s): Olanzapine 5mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer(s): Scherer DDS Ltd, Blagrove, Swindon, Wiltshire, England

Dated this 4th day of July 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of
February 1997).

go4702



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 71


Gazette.govt.nz PDF NZ Gazette 2001, No 71





✨ LLM interpretation of page content

πŸŽ“ Approval of Attendance Dues for Catholic Schools

πŸŽ“ Education, Culture & Science
5 July 2001
Attendance Dues, Catholic Schools, Integrated Schools, Private Schools Conditional Integration Act
  • KATHY PHILLIPS, Senior Manager, National Operations

πŸ₯ Appointment to the Medical Council of New Zealand

πŸ₯ Health & Social Welfare
3 July 2001
Medical Council, Appointment, Professor, Medical Practitioners Act
  • A. John Campbell (Professor), Appointed to Medical Council of New Zealand

  • ANNETTE KING, Minister of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
4 July 2001
Medicines, Distribution, Angiomax, Zyprexa Zydis, Bivalirudin, Olanzapine
  • G. R. BOYD, Chief Advisor, Safety and Regulation